Convergence of Engineering and Biology

The McDevitt lab is focused on the engineering of innovative technologies to translate the morphogenic potential of stem cells as models of development and disease, as well to develop cellular and molecular therapies aimed to treat degenerative diseases and traumatic injuries. Learn more about the research.

Since stem cells are promising for a number of applications, the emphasis of the McDevitt Lab is on the development of technology platforms to advance therapies that span multiple diseases.

Our technologies are applicable to a wide variety of diseases, including cardiovascular, orthopedic and neurological disorders. Specific diseases that we can apply our research to include treatments for diabetes, chronic wounds, aging, arthritis and other autoimmune disorders. The McDevitt lab's work also has other applications, including wound healing, irritable bowel syndrome, epilepsy and bone regeneration to name just a few. Click here for a complete list of research and disease applications.


  • Overview of Stem Cell Engineering
  • Todd was 1 of 6 panelists that toured Europe and Asia to do an international assessment of the Stem Cell Engineering field.


Biologists Being Basic featured the lab's COVID cardiac work.
Sarah Rockwood and Marty Krakora share what it is like to be a Research Associate at Gladstone.
Will Flanigan says thank you to the Gladstone Research Associates for their appreciation week.
Chosen based on demonstrated excellence and engagement in their field of research.
Todd McDevitt and Bruce Conklin comment on COVID-19 cardiac research
Gladstone scientists discover how the novel coronavirus damages heart muscle cells, and creates a system that can be used to screen potential therapies